YSB (HKSE:09885) EPS (Diluted) : HK$-25.99 (TTM As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is YSB EPS (Diluted)?

YSB's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$-0.07. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-25.99.

YSB's EPS (Basic) for the six months ended in Dec. 2023 was HK$-0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-25.99.

YSB's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.07. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-26.02.

During the past 3 years, the average EPS without NRIGrowth Rate was -105.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, YSB's highest 3-Year average EPS without NRI Growth Rate was -105.50% per year. The lowest was -105.50% per year. And the median was -105.50% per year.

YSB EPS (Diluted) Historical Data

The historical data trend for YSB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB EPS (Diluted) Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

-1.07

-0.97

-2.65

-9.04

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial			-	-1.18	-1.53	-25.92	-0.07

Competitive Comparison of YSB's EPS (Diluted)

For the Pharmaceutical Retailers subindustry, YSB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's PE Ratio distribution charts can be found below:

* The bar in red indicates where YSB's PE Ratio falls into.

YSB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

YSB's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-3507.21	-	0)	/	386.103
	=	-9.08

YSB's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-41.467	-	0)	/	640.486
	=	-0.06

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-25.99

YSB (HKSE:09885) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

YSB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of YSB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB (HKSE:09885) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines